Stocktoria
LIXTE BIOTECHNOLOGY HOLDINGS, INC. LIXT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2007-09-21
LIXTE BIOTECHNOLOGY HOLDINGS, INC. statistics & valuation
Market cap$125.0M
P / B11.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -47.7% | -313.0% | -118.1% | -113.5% | -132.1% |
| Return on equity | -55.5% | -433.5% | -127.3% | -122.2% | -140.5% |
| Current ratio | 3.88 | 3.60 | 13.73 | 14.05 | 16.81 |
Source: SEC EDGAR filings · CIK 0001335105 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.